Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics.
The underlying mechanisms of bronchoconstriction in aspirin-intolerant asthmatics (AIAs) are still unknown, but the hypothesis of an altered metabolism of arachidonic acid is generally accepted. So… Expand
Arachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin intolerant asthmatics.
Aspirin intolerance (AI) is characterized by polypous rhinosinusitis, bronchial asthma and adverse reactions to aspirin. The common intolerance to all cyclo-oxygenase inhibitors allows us to focus… Expand
Effect of acute consumption of oolong tea on antioxidant parameters in healthy individuals
Abstract We evaluated the ability of a ready-to-drink oolong tea (OOL) to modulate plasma antioxidant status in healthy subjects, compared to a placebo drink (PLA) without oolong extract but with… Expand
Total prevention of the development of in vitro tolerance to organic nitrates. Experiments with antioxidants.
The nearly total inhibition of development of pharmacological tolerance to an organic nitrate is reported here for the first time. The development of in vitro tolerance in the rabbit aorta to… Expand
Antagonism of glycerol trinitrate activity by an inhibitor of glutathione S-transferase.
The in vitro spasmolytic activity of glycerol trinitrate was measured on the KCl-contraction of aorta strips from the rabbit. In the presence of sulphobromophthalein, a known inhibitor of glutathione… Expand
Biomarkers of antioxidant status following ingestion of green teas at different polyphenol concentrations and antioxidant capacity in human volunteers.
- M. Pecorari, D. Villano, Maria Francesca Testa, M. Schmid, M. Serafini
- Chemistry, Medicine
- Molecular nutrition & food research
- 1 July 2010
In a randomized cross-over study, 15 healthy volunteers consumed 500 mL of green tea (GTFT) with different solid contents (1.4, 1.6, 1.8 and 2.0 g/L) to induce a dose-response effect on plasma… Expand
Formulations solid lipid comprising a lipase inhibitor and a fatty acid ester of polyols.
A pharmaceutical composition containing at least one inhibitor of lipases and at least one fatty acid ester of polyols, wherein the fatty acid ester has a melting point of> 37 ° C and the polyols are… Expand
Solid lipid formulation containing lipase inhibitor and fatty acid ester of polyols